UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000006288 |
|---|---|
| Receipt number | R000007435 |
| Scientific Title | Phase II Study of Primary Chemotherapy with Anthracycline-based Regimen Followed by Nab-paclitaxel and Trastuzumab in Patients with HER2 Positive Breast Cancer |
| Date of disclosure of the study information | 2011/09/05 |
| Last modified on | 2014/01/29 08:02:45 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/09/05 20:25:03 | ||
| 2 | Update | 2011/09/05 20:57:37 | Key inclusion criteria Key inclusion criteria |
|
| 3 | Update | 2011/09/05 21:13:00 | Key exclusion criteria |
|
| 4 | Update | 2011/09/09 00:11:22 | Interventions/Control_1 |
|
| 5 | Update | 2014/01/28 20:47:22 | Recruitment status |
|
| 6 | Update | 2014/01/28 20:48:18 | Email |
|
| 7 | Update | 2014/01/28 20:49:02 | Recruitment status |
|
| 8 | Update | 2014/01/29 08:02:46 | Key secondary outcomes Key secondary outcomes |
